Applied XL builds an AI-driven real-time data tracking platform that leverages machine learning and editorial algorithms to monitor dozens of databases and surface proprietary events and trends. Founded in 2020 and headquartered in New York, the company's engine applies a journalistic lens, enrichment layers, entity normalization, and ML classification to track thousands of daily changes and rank events by relevance. It augments its models with a network of experts who contribute data to retrain algorithms and improve accuracy. Applied XL's current product, Trials Pulse, was developed in partnership with STAT News to help pharma, biotech, and healthcare professionals navigate clinical-trial updates and inform regulatory, clinical-development, and investment decisions. The company reports 700+ users across global pharmaceutical companies, emerging biotech firms, and life-sciences investment funds, and says a number of customers are upgrading to an annual subscription priced at $1,500. With new funding, Applied XL plans to accelerate development of Trials Pulse and expand its coverage in the healthcare and life-sciences industry. Applied XL develops machine-learning tools that it describes as a swarm of "editorial algorithms" built by computational journalists and informed by journalistic principles like transparency and bias awareness. The company emerged from the Newlab Venture Studio last year and is led by CEO Francesco Marconi and CTO Erin Riglin. Applied XL says it will initially focus on the life sciences industry and plans a broad product launch this summer. Target customers include competitive intelligence teams at pharmaceutical companies and life sciences funds that need real-time, contextualized signals rather than raw database results. The founders compare their approach to how Bloomberg and Dow Jones collect and standardize financial data and envision building industry "micro models" across other categories over time. Financially, the startup recently closed a $1.5 million seed round to support its early product and go-to-market efforts.

Total raised

$5M

Funding rounds

2

Latest round

Seed

Latest activity

Mar 2022